Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Preliminary clinical outcome of novel strategy for the maximization of cumulative pregnancy rates per retrieval in normal responders.

Joo JK, Choi JR, Son JB, Ko GR, Lee KS.

Clin Exp Reprod Med. 2012 Mar;39(1):33-9. doi: 10.5653/cerm.2012.39.1.33. Epub 2012 Mar 31.

PMID:
22563549
[PubMed]
Free PMC Article
2.

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.

Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S.

Fertil Steril. 2011 May;95(6):2029-33, 2033.e1. doi: 10.1016/j.fertnstert.2011.01.163. Epub 2011 Mar 2.

PMID:
21371705
[PubMed - indexed for MEDLINE]
3.

Cryopreserved blastocyst transfer: impact of gonadotropin-releasing hormone agonist versus antagonist in the previous oocyte retrieval cycles.

Lee JR, Choi YS, Jee BC, Ku SY, Suh CS, Kim KC, Lee WD, Kim SH.

Fertil Steril. 2007 Nov;88(5):1344-9. Epub 2007 Jun 4.

PMID:
17548083
[PubMed - indexed for MEDLINE]
4.

Outcome of frozen-thawed blastocysts derived from gonadotropin releasing hormone agonist or antagonist cycles.

Medved R, Virant-Klun I, Meden-Vrtovec H, Tomazevic T.

J Assist Reprod Genet. 2006 Jun;23(6):275-9. Epub 2006 Jul 6.

PMID:
16823629
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study.

Griesinger G, von Otte S, Schroer A, Ludwig AK, Diedrich K, Al-Hasani S, Schultze-Mosgau A.

Hum Reprod. 2007 May;22(5):1348-52. Epub 2007 Feb 15.

PMID:
17303632
[PubMed - indexed for MEDLINE]
Free Article
7.

The effect of long zona dissection using ICSI pipettes for mechanical assisted hatching in vitrified-thawed blastocyst transfers.

Sun ST, Choi JR, Son JB, Joo JK, Ko GR, Lee KS.

J Assist Reprod Genet. 2012 Dec;29(12):1431-4. doi: 10.1007/s10815-012-9872-1. Epub 2012 Oct 6.

PMID:
23054363
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

[Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation].

Kdous M, Chaker A, Bouyahia M, Zhioua F, Zhioua A.

Tunis Med. 2009 Dec;87(12):834-42. French.

PMID:
20209851
[PubMed - indexed for MEDLINE]
Free Article
9.

Substituting HCG with GnRH agonist to trigger final follicular maturation--a retrospective comparison of three different ovarian stimulation protocols.

Orvieto R, Rabinson J, Meltzer S, Zohav E, Anteby E, Homburg R.

Reprod Biomed Online. 2006 Aug;13(2):198-201.

PMID:
16895632
[PubMed - indexed for MEDLINE]
10.

Frozen-thawed cleavage-stage embryo transfer cycles after previous GnRH agonist or antagonist stimulation.

Bahçeci M, Ulug U, Erden HF, Tosun S, Ciray N.

Reprod Biomed Online. 2009 Jan;18(1):67-72.

PMID:
19146771
[PubMed - indexed for MEDLINE]
11.

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.

Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O.

Fertil Steril. 2009 Feb;91(2):365-71. doi: 10.1016/j.fertnstert.2007.11.049. Epub 2008 Mar 25.

PMID:
18367175
[PubMed - indexed for MEDLINE]
12.

GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.

Griesinger G, Diedrich K, Devroey P, Kolibianakis EM.

Hum Reprod Update. 2006 Mar-Apr;12(2):159-68. Epub 2005 Oct 27. Review.

PMID:
16254001
[PubMed - indexed for MEDLINE]
Free Article
13.

Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates.

Radesic B, Tremellen K.

Hum Reprod. 2011 Dec;26(12):3437-42. doi: 10.1093/humrep/der333. Epub 2011 Oct 13.

PMID:
21997895
[PubMed - indexed for MEDLINE]
Free Article
15.

Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support.

Imbar T, Kol S, Lossos F, Bdolah Y, Hurwitz A, Haimov-Kochman R.

Hum Reprod. 2012 Mar;27(3):753-9. doi: 10.1093/humrep/der463. Epub 2012 Jan 16.

PMID:
22252086
[PubMed - indexed for MEDLINE]
Free Article
16.

In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.

Farhi J, Ben-Haroush A, Lande Y, Sapir O, Pinkas H, Fisch B.

Fertil Steril. 2009 Feb;91(2):377-82. doi: 10.1016/j.fertnstert.2007.11.086. Epub 2008 Mar 5.

PMID:
18321490
[PubMed - indexed for MEDLINE]
17.

[Clinical application of gonadotropin-releasing hormone antagonist in Chinese women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer].

Chen SL, Yin MN, Sun L, Li H, Chen X, Song HD, He JX, Zhu L, Xing FQ.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 May;27(5):588-90. Chinese.

PMID:
17545062
[PubMed - indexed for MEDLINE]
Free Article
18.

Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome.

Ragni G, Vegetti W, Riccaboni A, Engl B, Brigante C, Crosignani PG.

Hum Reprod. 2005 Sep;20(9):2421-5. Epub 2005 May 12.

PMID:
15890731
[PubMed - indexed for MEDLINE]
Free Article
19.

Performance of cryopreserved pre-embryos obtained in in vitro fertilization cycles with or without a gonadotropin-releasing hormone agonist.

Oehninger S, Toner JP, Veeck LL, Brzyski RG, Acosta AA, Muasher SJ.

Fertil Steril. 1992 Mar;57(3):620-5.

PMID:
1740208
[PubMed - indexed for MEDLINE]
20.

Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist, GnRH-antagonist/HCG or long protocol ovarian stimulation.

Eldar-Geva T, Zylber-Haran E, Babayof R, Halevy-Shalem T, Ben-Chetrit A, Tsafrir A, Varshaver I, Brooks B, Margalioth EJ.

Reprod Biomed Online. 2007 Feb;14(2):148-54.

PMID:
17298715
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk